1762 — Chunghwa Chemical Synthesis & Biotech Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Market Cap
TWD3.66bn
Enterprise Value
TWD4.60bn
Revenue
TWD2.09bn

Annual balance sheet for Chunghwa Chemical Synthesis & Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	101	149	195	301	270
Net Total Accounts Receivable
Net Total Receivables	172	368	396	312	257
Total Inventory
Prepaid Expenses
Total Current Assets	688	1,002	1,357	1,449	1,788
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,186	1,542	1,868	1,964	2,292
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,439	3,147	4,381	4,564	5,172
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	576	400	635	614	831
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,424	649	1,487	1,371	1,821
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	2,015	2,498	2,894	3,193	3,350
Total Liabilities & Shareholders' Equity	3,439	3,147	4,381	4,564	5,172
Total Common Shares Outstanding